Lanean...
First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension
Riociguat has been approved for use in adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. No clinical data on its therapeutic use in children with PAH are currently available. We report the case of a now four-year-old boy who initially presented at th...
Gorde:
| Argitaratua izan da: | Pulm Circ |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731721/ https://ncbi.nlm.nih.gov/pubmed/29099661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217743123 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|